Edgewise Therapeutics

What unites our cross-functional team beyond our mission to improve the lives of patients and families affected by serious muscle diseases? It’s our shared commitment to our core values: connection, excellence, and courage. These values are the building blocks of our dedication to innovation, and together, they drive our success in developing the next generation of muscle-focused medicines. #HCM #HypertrophicCardiomyopathy #Becker #Duchenne #MuscularDystrophy

It may take trial and error when determining the best exercises for a person with muscular dystrophy. Claudia Senesac, PT, PhD, PCS, Clinical Professor at Imaging NMD, shares her insights on the importance of tailoring workout programs to fit individual needs and how to recognize the warning signs when an exercise might be doing more harm than good. Learn more about exercising with muscular dystrophy in our quarterly patient newsletter. Tap the link to read it: https://bit.ly/4fmAWgX.

Consider a clinical trial in Becker muscular dystrophy (BMD): beckergcstudy.com

Meet Mario– living with Becker MD (BMD), a rare neuromuscular disorder that progressively weakens his muscles. Mario’s unwavering dedication to changing his perspective and inspiring those around him showcases his empowering nature and courageous spirit. Read how Mario’s navigating life with Becker here: https://lnkd.in/eMEarA7H. #BeckerMD #MuscularDystrophy

We're here in Prague for #WMS2024! Say hello to our team at Booth #21 and learn more about our work in muscle disease science and how we're transforming the future of treatments. We can't wait to see you! Kevin, Alan, Joanne, Behrad, Roxana, John, Nicholas, Abby, Lindsay, Emily

This year’s Becker Education and Engagement Day (BEED) was all about fostering connections and empowering those living with Becker muscular dystrophy. Edgewise was proud to sponsor and participate in this impactful event! Our team had the privilege of attending sessions at 6 locations across the U.S., where we learned from experts in Becker care and the community about crucial topics like cardiac health, exercise, and the realities of living with Becker. With over 330 attendees, we were thrilled to meet so many passionate community members and contribute to building a supportive, dedicated network for Becker. Thank you to everyone who made this event unforgettable! Share your favorite BEED moment with us in the comments below!

It's Becker Awareness Week (Oct 6 - Oct 13)! Join us in raising awareness about Becker Muscular Dystrophy (BMD) and making a difference. "Every day, we follow science to bring the potential of muscle-targeted therapeutics to the communities we serve." - Joanne Donovan, M.D., Ph.D., Chief Medical Officer

Members of the Edgewise team are headed to Prague for #WMS2024! Join neuromuscular experts, Luca Bello and Craig McDonald, for our scientific symposium “Understanding disease progression and a potential novel agent to protect muscle,” taking place on Oct 8 at 4:30pm CEST, and check out our seven poster presentations! Learn more here: https://lnkd.in/eAVEDyHD. Don’t forget to stop by booth #21 and say hello to our team: Kevin, Alan, Joanne, Behrad, Roxana, John, Nicholas, Abby, Lindsay Nelson, and Emily. See you in Prague!

We’re headed to Atlanta, Georgia for Muscular Dystrophy Association Engage to connect with the patient community! Abby Bronson will be participating in the Drug Development Roundtable taking place on Oct 5. To learn more about the symposium, or to register, visit: https://lnkd.in/e-ivaF8S. See you there! #BeckerMD #BeckerDiseaseAwarenessWeek #MuscularDystrophy #Duchenne

Joanne Donovan, M.D., Chief Medical Officer at Edgewise Therapeutics, was recently interviewed by Know Rare about our clinical development program in Becker muscular dystrophy. Listen to the full interview here: https://lnkd.in/ggxKiXws